Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

1.

Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.

Erdmann JI, Morak MJ, Duivenvoorden HJ, van Dekken H, Kazemier G, Kok NF, van Eijck CH.

HPB (Oxford). 2015 Mar 20. doi: 10.1111/hpb.12401. [Epub ahead of print]

PMID:
25800041
2.

Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.

Koen Talsma A, Shapiro J, Looman CW, van Hagen P, Steyerberg EW, van der Gaast A, van Berge Henegouwen MI, Wijnhoven BP, van Lanschot JJ; CROSS Study Group, Hulshof MC, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW.

Ann Surg. 2014 Nov;260(5):786-92; discussion 792-3. doi: 10.1097/SLA.0000000000000965.

PMID:
25379850
3.

Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer.

van der Zee JA, Ten Hagen TL, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, van Eijck CH.

Eur J Cancer. 2013 Jan;49(2):323-8. doi: 10.1016/j.ejca.2012.07.030. Epub 2012 Aug 29.

PMID:
22939115
4.

Cyst-like schwannoma on the eyelid margin.

Cheng KH, Karres J, Kros JM, Kijlstra A, van Dekken H.

J Craniofac Surg. 2012 Jul;23(4):1215-6. doi: 10.1097/SCS.0b013e3182564ace.

PMID:
22801133
5.

Preoperative chemoradiotherapy for esophageal or junctional cancer.

van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A; CROSS Group.

N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.

6.

Expression and prognostic significance of thymidylate synthase (TS) in pancreatic head and periampullary cancer.

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, Ten Hagen TL.

Eur J Surg Oncol. 2012 Nov;38(11):1058-64. doi: 10.1016/j.ejso.2012.04.013. Epub 2012 May 24.

PMID:
22633450
7.

The role of pathology in small renal mass laparoscopic cryoablation.

Lagerveld BW, van Dekken H, van Leenders GJ, van der Zee JA.

Adv Urol. 2012;2012:539648. doi: 10.1155/2012/539648. Epub 2012 Mar 19.

8.

Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.

Menke V, Pot RG, Moons LM, van Zoest KP, Hansen B, van Dekken H, Siersema PD, Kusters JG, Kuipers EJ.

J Hum Genet. 2012 Jan;57(1):26-32. doi: 10.1038/jhg.2011.124. Epub 2011 Dec 1.

PMID:
22129558
9.

The heart is not too noble to host a metastatic tumor! A right ventricle metastasis of a transitional cell carcinoma of the bladder.

Selder JL, van Dekken H, de Voogt WG.

Neth Heart J. 2015 Jan;23(1):74-6. doi: 10.1007/s12471-011-0212-3. No abstract available.

10.

Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.

van de Winkel A, Menke V, Capello A, Moons LM, Pot RG, van Dekken H, Siersema PD, Kusters JG, van der Laan LJ, Kuipers EJ.

BMC Gastroenterol. 2011 Oct 6;11:108. doi: 10.1186/1471-230X-11-108.

11.

Angiogenesis: a prognostic determinant in pancreatic cancer?

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, ten Hagen TL.

Eur J Cancer. 2011 Nov;47(17):2576-84. doi: 10.1016/j.ejca.2011.08.016. Epub 2011 Sep 28.

PMID:
21958461
12.

Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening.

van Putten PG, Hol L, van Dekken H, Han van Krieken J, van Ballegooijen M, Kuipers EJ, van Leerdam ME.

Histopathology. 2011 May;58(6):974-81. doi: 10.1111/j.1365-2559.2011.03822.x.

PMID:
21585430
13.

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.

Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ, Giard R, Lesterhuis W, Heinhuis R, Klinkenberg EC, Meijer GA, ter Borg F, Arends JW, Kolkman JJ, van Baarlen J, de Vries RA, Mulder AH, van Tilburg AJ, Offerhaus GJ, ten Kate FJ, Kusters JG, Kuipers EJ, Siersema PD.

Am J Gastroenterol. 2011 Jul;106(7):1231-8. doi: 10.1038/ajg.2011.153. Epub 2011 May 17.

PMID:
21577245
14.

Bovine antibody-based oral immunotherapy for reduction of intragastric Helicobacter pylori colonization: a randomized clinical trial.

den Hoed CM, de Vries AC, Mensink PB, Dierikx CM, Suzuki H, Capelle L, van Dekken H, Ouwendijk R, Kuipers EJ.

Can J Gastroenterol. 2011 Apr;25(4):207-13.

15.

Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study.

Gerrits MM, Chen M, Theeuwes M, van Dekken H, Sikkema M, Steyerberg EW, Lingsma HF, Siersema PD, Xia B, Kusters JG, van der Woude CJ, Kuipers EJ.

Cell Oncol (Dordr). 2011 Apr;34(2):107-17. doi: 10.1007/s13402-010-0006-4. Epub 2011 Feb 17.

16.

Differential expression of the nuclear receptors farnesoid X receptor (FXR) and pregnane X receptor (PXR) for grading dysplasia in patients with Barrett's oesophagus.

van de Winkel A, van Zoest KP, van Dekken H, Moons LM, Kuipers EJ, van der Laan LJ.

Histopathology. 2011 Jan;58(2):246-53. doi: 10.1111/j.1365-2559.2011.03743.x.

PMID:
21323950
17.

The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer.

den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ.

Eur J Cancer. 2011 May;47(8):1211-8. doi: 10.1016/j.ejca.2010.12.012. Epub 2011 Jan 14.

18.

Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.

van Heijl M, Omloo JM, van Berge Henegouwen MI, Hoekstra OS, Boellaard R, Bossuyt PM, Busch OR, Tilanus HW, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Cuesta MA, Ten Kate FJ, Pruim J, van Dekken H, Bergman JJ, Sloof GW, van Lanschot JJ.

Ann Surg. 2011 Jan;253(1):56-63. doi: 10.1097/SLA.0b013e3181f66596.

PMID:
21233607
19.

Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.

van der Zee JA, ten Hagen TL, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, van Eijck CH.

Eur J Cancer. 2010 Dec;46(18):3393-9. doi: 10.1016/j.ejca.2010.07.024. Epub 2010 Aug 17.

PMID:
20724141
20.

Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions.

de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ.

Helicobacter. 2010 Aug;15(4):259-64. doi: 10.1111/j.1523-5378.2010.00760.x.

PMID:
20633186
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk